Abstract:OBJECTIVE:To study the changes of inflammatory path molecules in the islet alpha cells in high-fat-diet fed plus beta cell-deleted rat models and the effects of pioglitazone intervention.METHODS:Forty five normal male SD rats, 8 week old, were randomly divided into 3 groups, i.e., a normal diet group (NC), a high fat diet fed group (HF), and a high fat diet fed and pioglitazone treated group (HP, pioglitazone 15 mg kg(-1) d(-1)). At the end of twenty weeks of feeding, fasting serum insulin (FIns), glucagon, free fatty acid (FFA) and high sensitive C reactive protein (hsCRP) were determined. Glucose infusion rate (GIR) was measured by using euglycemic hyperinsulinemia clamp to evaluate the peripheral insulin resistance. The contents of glucagon in perfusion medium during islet cell perfusion was measured with RIA. At the same time, beta cell-deleted rat models were established by injecting large dose streptozocin (100 mg/kg) in 8 rats in each of the three groups, i.e., HF-B group, P-B group and NC-B group. Five days later, the rats were sacrificed and the pancreatic islets were isolated and collected. The expression of NF-kappaB and inhibitor kappaBalpha (IkappaBalpha) gene in the islets was detected with real-time PCR.RESULTS:(1) GIR was decreased significantly in HF group as compared with NC group (P < 0.01). The concentrations of serum FIns, glucagon, FFA and hsCRP in HF group were higher than those in NC group. Pioglitazone intervention could reverse these effects. (2) 16.7 mmol/L glucose could inhibit the glucagon secretion by the islet alpha cells of the NC group rats, but not of the HF group rats. Pioglitazone intervention could reverse these effects. (3) The gene expression of NF-kappaB was significantly increased by 20.5% in the HF-B group than in the NC-B group (P < 0.01). In contrast, the expression of IkappaBalpha was significantly decreased by 24.3% (P < 0.01). The expression of NF-kappaB and IkappaBalpha mRNAs in HP-B group, when compared with that of HF-B group, was improved 78.3% and 58.8%, respectively.CONCLUSIONS:High-fat-diet feeding induces islet alpha cell insulin resistance and activates the mRNA expression of inflammatory path molecules in beta cell-deleted rat models and it may relate with the increased plasma FFA concentration. Pioglitazone intervention can reverse these effects.

[Inhibitory Effects of Thiazolidinedione Upon Cytokine-Induced Apoptosis in Pancreatic Beta-Cell Line].

Thiazolidinediones Protect Mouse Pancreatic Β-Cells Directly from Cytokine-Induced Cytotoxicity Through PPARγ-dependent Mechanisms

Glitazones Protects Beta Cell Function from Cytotoxic Cytokines Through PPAR Gammadependent Mechanisms

Protective effect of pioglitazone on islet cell apoptosis induced by proinflammatory cytokines

Inhibitory Effect of Pioglitazone on TGF-β1 Gene Expression in Renal Cortex of Diabetic Rats

Cytotoxicity and toxicoproteomics analysis of thiazolidinedione exposure in human‐derived cardiomyocytes

Glucagon-Like Peptide-1 Analog-Mediated Protection Against Cholesterol-Induced Apoptosis Via Mammalian Target Of Rapamycin Activation In Pancreatic Beta Tc-6 Cells

Epigallocatechin-3-gallate Protects Pro-Inflammatory Cytokine Induced Injuries in Insulin-Producing Cells Through the Mitochondrial Pathway.

Concurrently Using Rosiglitazone Prevents Glucosamine-Induced Islet Beta-Cell Apoptosis and Dysfunction.

Protective effects of pioglitazone on vascular endothelial cell dysfunction induced by high glucose via inhibition of IKKα/β-NFκB signaling mediated by PPARγ in vitro.

IGF-1 ameliorates streptozotocin-induced pancreatic β cell dysfunction and apoptosis via activating IRS1/PI3K/Akt/FOXO1 pathway

Pioglitazone Attenuate Oxidative Stress Induced Insulin Resistance in Adipocytes

PPARγ-independent Antitumor Effects of Thiazolidinediones

The inhibitory effect of troglitazone on macrophage differentiation mediated by repressing NF-κB ctivation independently of PPARγ

Troglitazone Induced Apoptosis Via PPARγ Activated POX-induced ROS Formation in HT29 Cells.

Rosiglitazone Inhibits High Glucose-Induced Apoptosis in Human Umbilical Vein Endothelial Cells Through the PI3K/Akt/eNOS Pathway

Inhibitory Effects of Rosiglitazone on the Expression of Transforming Growth Factor-β_1 in Rat Mesangial Cells Cultured in High Glucose

[The Relationship Between Islet Alpha Cell Insulin Resistance and Inflammatory Pathway Activation and Its Mechanism].

Protective Effects of Rosiglitazone on Retinal Neuronal Damage in Diabetic Rats

[1Α, 25(OH)(2) D(3) Protects Pancreatic Β-Cell Line from Cytokine-Induced Apoptosis and Impaired Insulin Secretion].

Pioglitazone Modulates the Proliferation and Apoptosis of Vascular Smooth Muscle Cells Via Peroxisome Proliferators-Activated Receptor-Gamma